117 related articles for article (PubMed ID: 32172855)
1. Nanoparticles assembled from fucoidan and trimethylchitosan as anthrax vaccine adjuvant: In vitro and in vivo efficacy in comparison to CpG.
Tsai MH; Chuang CC; Chen CC; Yen HJ; Cheng KM; Chen XA; Shyu HF; Lee CY; Young JJ; Kau JH
Carbohydr Polym; 2020 May; 236():116041. PubMed ID: 32172855
[TBL] [Abstract][Full Text] [Related]
2. A fucoidan-quaternary chitosan nanoparticle adjuvant for anthrax vaccine as an alternative to CpG oligodeoxynucleotides.
Chuang CC; Tsai MH; Yen HJ; Shyu HF; Cheng KM; Chen XA; Chen CC; Young JJ; Kau JH
Carbohydr Polym; 2020 Feb; 229():115403. PubMed ID: 31826481
[TBL] [Abstract][Full Text] [Related]
3. Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax.
Malik A; Gupta M; Mani R; Gogoi H; Bhatnagar R
Front Immunol; 2018; 9():562. PubMed ID: 29616046
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of the humoral and cellular immunity induced by live A16R attenuated spore and AVA-like anthrax vaccine in mice.
Lv J; Zhang YY; Lu X; Zhang H; Wei L; Gao J; Hu B; Hu WW; Hu DZ; Jia N; Feng X
Biologicals; 2017 Mar; 46():130-138. PubMed ID: 28215694
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
Bento D; Staats HF; Gonçalves T; Borges O
Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
[TBL] [Abstract][Full Text] [Related]
6. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK
J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336
[TBL] [Abstract][Full Text] [Related]
7. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
Welkos S; Little S; Friedlander A; Fritz D; Fellows P
Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
[TBL] [Abstract][Full Text] [Related]
8. Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909).
Minang JT; Inglefield JR; Harris AM; Lathey JL; Alleva DG; Sweeney DL; Hopkins RJ; Lacy MJ; Bernton EW
Vaccine; 2014 Nov; 32(50):6847-54. PubMed ID: 24530403
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
[TBL] [Abstract][Full Text] [Related]
10. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
11. CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine.
Klinman DM; Xie H; Ivins BE
Ann N Y Acad Sci; 2006 Oct; 1082():137-50. PubMed ID: 17145935
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
[TBL] [Abstract][Full Text] [Related]
13. CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine.
Klinman DM
Expert Rev Vaccines; 2006 Jun; 5(3):365-9. PubMed ID: 16827620
[TBL] [Abstract][Full Text] [Related]
14. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR
J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444
[TBL] [Abstract][Full Text] [Related]
15. Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.
Rynkiewicz D; Rathkopf M; Sim I; Waytes AT; Hopkins RJ; Giri L; DeMuria D; Ransom J; Quinn J; Nabors GS; Nielsen CJ
Vaccine; 2011 Aug; 29(37):6313-20. PubMed ID: 21624418
[TBL] [Abstract][Full Text] [Related]
16. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against
Majumder S; Das S; Somani VK; Makam SS; Kingston JJ; Bhatnagar R
Front Immunol; 2019; 10():498. PubMed ID: 30941133
[TBL] [Abstract][Full Text] [Related]
17. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
18. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.
Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO
Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494
[TBL] [Abstract][Full Text] [Related]
20. A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.
Kachura MA; Hickle C; Kell SA; Sathe A; Calacsan C; Kiwan R; Hall B; Milley R; Ott G; Coffman RL; Kanzler H; Campbell JD
J Immunol; 2016 Jan; 196(1):284-97. PubMed ID: 26608924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
